04:27 AM EST, 02/10/2026 (MT Newswires) -- Astrazeneca ( AZN ) reported Q4 core earnings Tuesday of $2.12 per share, up 1% from a year earlier.

Analysts polled by FactSet expected $2.11.

Revenue for the quarter ended Dec. 31 was $15.50 billion, up from $14.89 billion a year earlier.

Analysts surveyed by FactSet expected $15.46 billion.

For 2026, the company expects core EPS to rise by a low double-digit percentage and revenue to grow by a mid-to-high single-digit percentage at constant exchange rates.

Astrazeneca ( AZN ) said that in 2026, it plans to increase the annual dividend declared to $3.30 per share.

The company's shares were up 1.5% in recent premarket activity.